{"count": 7, "results": [{"_id": "34086261", "pmid": 34086261, "pmcid": "PMC8460565", "title": "The impact of rosuvastatin on hypothalamic-pituitary-testicular axis activity in metformin-treated and metformin-naive men with low testosterone levels: a pilot study", "journal": "Pharmacol Rep", "authors": ["Krysiak R", "Basiak M", "Szkróbka W", "Okopień B"], "date": "2021-10-01T00:00:00Z", "doi": "10.1007/s43440-021-00289-1", "meta_date_publication": "2021 Oct", "meta_volume": "73", "meta_issue": "5", "meta_pages": "1465-1472", "score": 50260.39, "text_hl": "The study included 43 very high cardiovascular risk @SPECIES_9606 @@@men@@@ with late-onset @<m>DISEASE_Hypogonadism</m> @DISEASE_MESH:D007006 @@@hypogonadism@@@, 20 of whom had been treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (1.7-3 g daily) for at least 6 months. ", "citations": {"NLM": "Krysiak R, Basiak M, Szkróbka W, Okopień B. The impact of rosuvastatin on hypothalamic-pituitary-testicular axis activity in metformin-treated and metformin-naive men with low testosterone levels: a pilot study Pharmacol Rep. 2021 Oct;73(5):1465-1472. PMID: 34086261", "BibTeX": "@article{34086261, title={The impact of rosuvastatin on hypothalamic-pituitary-testicular axis activity in metformin-treated and metformin-naive men with low testosterone levels: a pilot study}, author={Krysiak R and Basiak M and Szkróbka W and Okopień B}, journal={Pharmacol Rep}, volume={73}, number={5}, pages={1465-1472}}"}}, {"_id": "32813271", "pmid": 32813271, "title": "Plasma gonadotropin levels in metformin-treated men with prediabetes: a non-randomized, uncontrolled pilot study.", "journal": "Fundam Clin Pharmacol", "authors": ["Krysiak R", "Szkróbka W", "Bednarska-Czerwińska A", "Okopień B"], "date": "2021-04-01T00:00:00Z", "doi": "10.1111/fcp.12600", "meta_date_publication": "2021 Apr", "meta_volume": "35", "meta_issue": "2", "meta_pages": "466-472", "score": 50258.965, "text_hl": "The results of our study suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may decrease FSH and LH levels in @SPECIES_9606 @@@men@@@ with @<m>DISEASE_Hypogonadism</m> @DISEASE_MESH:D007006 @@@hypergonadotropic hypogonadism@@@.", "citations": {"NLM": "Krysiak R, Szkróbka W, Bednarska-Czerwińska A, Okopień B. Plasma gonadotropin levels in metformin-treated men with prediabetes: a non-randomized, uncontrolled pilot study. Fundam Clin Pharmacol. 2021 Apr;35(2):466-472. PMID: 32813271", "BibTeX": "@article{32813271, title={Plasma gonadotropin levels in metformin-treated men with prediabetes: a non-randomized, uncontrolled pilot study.}, author={Krysiak R and Szkróbka W and Bednarska-Czerwińska A and Okopień B}, journal={Fundam Clin Pharmacol}, volume={35}, number={2}, pages={466-472}}"}}, {"_id": "34490645", "pmid": 34490645, "title": "Hypothalamic-pituitary-gonadal axis and sexual functioning in metformin-treated men after discontinuation of testosterone replacement therapy: A pilot study.", "journal": "J Clin Pharm Ther", "authors": ["Krysiak R", "Kowalcze K", "Okopień B"], "date": "2021-12-01T00:00:00Z", "doi": "10.1111/jcpt.13528", "meta_date_publication": "2021 Dec", "meta_volume": "46", "meta_issue": "6", "meta_pages": "1764-1775", "score": 50252.43, "text_hl": "The control group included 16 @CHEMICAL_Testosterone @CHEMICAL_MESH:D013739 @@@testosterone@@@- and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated @SPECIES_9606 @@@men@@@ with late-onset @<m>DISEASE_Hypogonadism</m> @DISEASE_MESH:D007006 @@@hypogonadism@@@ who during the entire study period continued their treatment. ", "citations": {"NLM": "Krysiak R, Kowalcze K, Okopień B. Hypothalamic-pituitary-gonadal axis and sexual functioning in metformin-treated men after discontinuation of testosterone replacement therapy: A pilot study. J Clin Pharm Ther. 2021 Dec;46(6):1764-1775. PMID: 34490645", "BibTeX": "@article{34490645, title={Hypothalamic-pituitary-gonadal axis and sexual functioning in metformin-treated men after discontinuation of testosterone replacement therapy: A pilot study.}, author={Krysiak R and Kowalcze K and Okopień B}, journal={J Clin Pharm Ther}, volume={46}, number={6}, pages={1764-1775}}"}}, {"_id": "35957837", "pmid": 35957837, "pmcid": "PMC9359072", "title": "Early-Onset Diabetes Mellitus in Chromosome 8p11.2 Deletion Syndrome Combined With Becker Muscular Dystrophy - A Case Report", "journal": "Front Endocrinol (Lausanne)", "authors": ["Cao C", "Wang X", "Zhao X"], "date": "2022-07-25T00:00:00Z", "doi": "10.3389/fendo.2022.914863", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "914863", "score": 50232.08, "text_hl": "Laboratory examination indicated @DISEASE_Anemia @DISEASE_MESH:D000740 @@@spherocytosis anemia@@@, and @<m>DISEASE_Hypogonadism</m> @DISEASE_MESH:D007006 @@@hypogonadotropic hypogonadism@@@. ", "citations": {"NLM": "Cao C, Wang X, Zhao X. Early-Onset Diabetes Mellitus in Chromosome 8p11.2 Deletion Syndrome Combined With Becker Muscular Dystrophy - A Case Report Front Endocrinol (Lausanne). 2022;13():914863. PMID: 35957837", "BibTeX": "@article{35957837, title={Early-Onset Diabetes Mellitus in Chromosome 8p11.2 Deletion Syndrome Combined With Becker Muscular Dystrophy - A Case Report}, author={Cao C and Wang X and Zhao X}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={914863}}"}}, {"_id": "26447645", "pmid": 26447645, "title": "Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.", "journal": "Andrology", "authors": ["Giagulli VA", "Carbone MD", "Ramunni MI", "Licchelli B", "De Pergola G", "Sabbà C", "Guastamacchia E", "Triggiani V"], "date": "2015-11-01T00:00:00Z", "doi": "10.1111/andr.12099", "meta_date_publication": "2015 Nov", "meta_volume": "3", "meta_issue": "6", "meta_pages": "1094-103", "score": 50057.535, "text_hl": "Adding liraglutide to lifestyle changes, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @CHEMICAL_Testosterone @CHEMICAL_MESH:D013739 @@@testosterone@@@ therapy boosts erectile function in @DISEASE_Obesity @DISEASE_MESH:D009765 @@@diabetic obese@@@ @SPECIES_9606 @@@men@@@ with overt @<m>DISEASE_Hypogonadism</m> @DISEASE_MESH:D007006 @@@hypogonadism@@@.", "citations": {"NLM": "Giagulli VA, Carbone MD, Ramunni MI, Licchelli B, De Pergola G, Sabbà C, Guastamacchia E, Triggiani V. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism. Andrology. 2015 Nov;3(6):1094-103. PMID: 26447645", "BibTeX": "@article{26447645, title={Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.}, author={Giagulli VA and Carbone MD and Ramunni MI and Licchelli B and De Pergola G and Sabbà C and Guastamacchia E and Triggiani V}, journal={Andrology}, volume={3}, number={6}, pages={1094-103}}"}}, {"_id": "26721356", "pmid": 26721356, "title": "The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride.", "journal": "Pharmacol Rep", "authors": ["Krysiak R", "Gilowski W", "Okopień B"], "date": "2016-02-01T00:00:00Z", "doi": "10.1016/j.pharep.2015.06.003", "meta_date_publication": "2016 Feb", "meta_volume": "68", "meta_issue": "1", "meta_pages": "75-9", "score": 50056.61, "text_hl": "The effect of @CHEMICAL_Testosterone @CHEMICAL_MESH:D013739 @@@testosterone@@@ on cardiovascular risk factors in @SPECIES_9606 @@@men@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ and late-onset @<m>DISEASE_Hypogonadism</m> @DISEASE_MESH:D007006 @@@hypogonadism@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or @CHEMICAL_glimepiride @CHEMICAL_MESH:C057619 @@@glimepiride@@@.", "citations": {"NLM": "Krysiak R, Gilowski W, Okopień B. The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride. Pharmacol Rep. 2016 Feb;68(1):75-9. PMID: 26721356", "BibTeX": "@article{26721356, title={The effect of testosterone on cardiovascular risk factors in men with type 2 diabetes and late-onset hypogonadism treated with metformin or glimepiride.}, author={Krysiak R and Gilowski W and Okopień B}, journal={Pharmacol Rep}, volume={68}, number={1}, pages={75-9}}"}}, {"_id": "26600057", "pmid": 26600057, "title": "The Effect of Metformin and Metformin-Testosterone Combination on Cardiometabolic Risk Factors in Men with Late-onset Hypogonadism and Impaired Glucose Tolerance.", "journal": "Exp Clin Endocrinol Diabetes", "authors": ["Krysiak R", "Gilowski W", "Okopien B"], "date": "2015-11-01T00:00:00Z", "doi": "10.1055/s-0035-1564070", "meta_date_publication": "2015 Nov", "meta_volume": "123", "meta_issue": "10", "meta_pages": "608-13", "score": 50053.246, "text_hl": "No previous study has investigated the effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, administered alone or together with @CHEMICAL_Testosterone @CHEMICAL_MESH:D013739 @@@testosterone@@@, on cardiometabolic risk factors in @SPECIES_9606 @@@men@@@ with @<m>DISEASE_Hypogonadism</m> @DISEASE_MESH:D007006 @@@hypogonadism@@@. ", "citations": {"NLM": "Krysiak R, Gilowski W, Okopien B. The Effect of Metformin and Metformin-Testosterone Combination on Cardiometabolic Risk Factors in Men with Late-onset Hypogonadism and Impaired Glucose Tolerance. Exp Clin Endocrinol Diabetes. 2015 Nov;123(10):608-13. PMID: 26600057", "BibTeX": "@article{26600057, title={The Effect of Metformin and Metformin-Testosterone Combination on Cardiometabolic Risk Factors in Men with Late-onset Hypogonadism and Impaired Glucose Tolerance.}, author={Krysiak R and Gilowski W and Okopien B}, journal={Exp Clin Endocrinol Diabetes}, volume={123}, number={10}, pages={608-13}}"}}]}